002898.SZ

Sailong Pharmaceutical Group Co., Ltd. [002898.SZ] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

002898.SZ Stock Summary

Top 10 Correlated ETFs

002898.SZ

Top 10 Correlated Stocks

002898.SZ

In the News

002898.SZ Financial details

Company Rating
-
Market Cap
1.93B
Income
-34.69M
Revenue
296.73M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
464
Optionable
No
Shortable
Yes
Earnings
30 Apr 2021
P/E
-69.27
Forward P/E
-
PEG
-13.77
P/S
8.1
P/B
4.53
P/C
-
P/FCF
-37.75
Quick Ratio
0.61
Current Ratio
1.04
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.2
EPS next Y
-
EPS next Q
-
EPS this Y
61.54%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
-9.55%
Revenue Q/Q
-11.33%
EPS Q/Q
-733.33%
-
-
-
-
SMA20
-20.1%
SMA50
-37.6%
SMA100
-42.65%
Inst Own
-
Inst Trans
-
ROA
-4%
ROE
-7%
ROC
-0.04%
Gross Margin
47%
Oper. Margin
-7%
Profit Margin
-12%
Payout
-16%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
7.7-20.02
52W High
-68.7%
52W Low
-10.57%
RSI
30.3
Rel Volume
1.21
Avg Volume
8.23M
Volume
9.98M
Perf Week
-8.61%
Perf Month
-31.58%
Perf Quarter
-37.77%
Perf Half Y
-42.83%
-
-
-
-
Beta
0.121
-
-
Volatility
0.21%, 0.8%
Prev Close
4.86%
Price
6.26
Change
5.92%

Something similar

Top by Market Cap
LLY.SW
0YXG.L
APC.DE
BRK-B
AAPL
Top Correlated ETFs
VRIG
FHI.TO
HDRO
UNL
HUN.TO
Top Correlated Stocks
000826.SZ
002323.SZ
300383.SZ
000929.SZ
002076.SZ
Similar Market Cap
EMLC
002295.SZ
1596.HK
0K7J.L
RAT.L

Company Profile

Healthcare Biotechnology
  • Volume Average 8.23M
  • Market Capitalization 1.93B
  • Employee 464
  • CEO Mr. Jian Feng Li
  • Headquarters Zhuhai,CN
  • IPO Date 2017-09-13
  • Website https://www.sailong.cn

Sailong Pharmaceutical Group Co., Ltd. researches, develops, produces, markets, and services pharmaceutical intermediates, raw materials, and preparations in China. The company offers esomeprazole sodium, ornithine aspartate, thymus, argatroban, gaicycline, monosialotetrahexose ganglioside sodium, cerebroprotein hydrolysate, milrinone, parecoxib sodium, tranexamic acid, clindamycin phosphate, and pantoprazole sodium products. It provides its products for therapeutic areas, such as cardiovascular, cerebrovascular, nerve, digestive system, proton pump inhibitors, anti-infectives, anti-bleeding medicine, analgesics, and other fields. The company was formerly known as Zhuhai Sailong Pharmaceutical Co.,Ltd. and changed its name to Sailong Pharmaceutical Group Co., Ltd. in September 2021. Sailong Pharmaceutical Group Co., Ltd. was founded in 2002 and is based in Zhuhai, China.